RT Journal Article
SR Electronic
T1 The association of ABO blood group with the asymptomatic COVID-19 cases in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.01.21254681
DO 10.1101/2021.04.01.21254681
A1 Prajjval Pratap Singh
A1 Abhishek K Srivastava
A1 Sudhir K Upadhyay
A1 Ashish Singh
A1 Pranav Gupta
A1 Sanjeev Maurya
A1 Shashank Upadhyay
A1 Rudra Kumar Pandey
A1 Anshika Srivastava
A1 Priya Dev
A1 Vanya Singh
A1 Rahul Mishra
A1 Manoj Kumar Shukla
A1 Govind Chaubey
A1 Pradeep Kumar
A1 Vandana Rai
A1 Yamini B Tripathi
A1 Abhishek Pathak
A1 Vijay Nath Mishra
A1 Chandana Basu Mallick
A1 Pankaj Shrivastava
A1 Gyaneshwer Chaubey
YR 2021
UL http://medrxiv.org/content/early/2021/04/06/2021.04.01.21254681.abstract
AB The COVID-19 pandemic has resulted several waves of infection in many countries worldwide. The large variations in case fatality ratio among different geographical regions suggests that the human susceptibility against this virus varies substantially. Several studies from different parts of the world showed a significant association of ABO blood group and COVID-19 susceptibility. It was shown that individuals with blood group O are at the lower risk of coronavirus infection. To establish the association of ABO blood group in SARS-CoV-2 susceptibility, we for the first time analysed SARS-CoV-2 neutralising antibodies as well as blood groups among 509 random individuals from three major districts of Eastern Uttar Pradesh region of India.. Interestingly, we found neutralising antibodies in significantly higher percentage of people with blood group AB (0.36) followed by B (0.31), A (0.22) and lowest in people with blood group O (0.11). This indicates that people with blood group AB are at comparatively higher risk of infection than other blood groups. Further, in line to previous reports we too observed that people with blood group O have significantly decreased risk of SARS-CoV-2 infection. Thus, among the asymptomatic SARS-CoV-2 infected individuals with blood group AB has highest, whilst blood group O has lowest risk of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe did not receive any specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project has been approved by the Institutional ethical committe of Banaras Hindu University, Varanasi, IndiaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is available with the manuscript.